Product Images Metoprolol Succinate Extended-release

This appears to be a chart or graph presenting information on a study involving Metoprolol and Placebo administered to patients hospitalized for heart failure. The study tracks the time to the first event i.e. either hospitalization or death for patients with both ischemic and non-ischemic etiology, separated by gender and race. Information about the patient's heart rate, ejection fraction and previous health conditions like diabetes and hypertension are also provided. The chart shows a comparison between Metoprolol and Placebo, indicating the relative risk and 95% confidence interval.*

This is a prescription drug with NDC code 56177-253-04 named Metoprolol Succinate. It is available in the form of extended-release tablets with a strength of 25 mg and 100 tablets per bottle. The manufacturer of this drug is Ethex.*

This text seems to be the product information of metoprolol tartrate, USP extended-release tablets, USP manufactured by KV Pharmaceutical Co. It advises keeping the medicine in a child-resistant place and at temperatures between 20-25°C. The standard dosage information is not available in this text.*

Metoprolol Succinate is a drug prescribed for a variety of heart and cardiovascular conditions. The tablets shown have an NDC number of 58177-293-12, contain 23.75mg of metoprolol succinate or 25mg metoprolol tartrate, and are extended-release. The package includes 5000 tablets and usual dosage depends on the patient’s specific medical situation. Proper storage between 20 to 25C/ 68-77F in light-resistant packaging is important, and all drugs should be kept away from children. Additional information should be found in the accompanying package outsert.*